STOCK TITAN
  1. Home
  2. Financials
  3. NNBXF
  4. Revenue

Nanobiotix Labege (NNBXF) Revenue by Year

NNBXF OTC

Nanobiotix Labege generated $38.3M in revenue in fiscal year 2025. The table below carries 8 fiscal years, from 2018 to 2025.

FY2025 annual
Revenue $38.3M
Source SEC Filings Latest period FY2025, ended Dec 31, 2025 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

NNBXF Revenue by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY25FilingFY24FilingFY23FilingFY22FilingFY21FilingFY20FilingFY19FilingFY18Filing
Revenue$38.3MN/A$40.1M+683.9%$5.1M+70.5%$3.0M-2.5%$3.1M+7.7%$2.9M-28.4%$4.0M

What revenue means

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.

More Nanobiotix Labege financials

Frequently Asked Questions

Nanobiotix Labege generated $38.3M in revenue in fiscal year 2025.

Across the 8 fiscal years this page covers, Nanobiotix Labege (NNBXF) revenue went from $4.0M in fiscal year 2018 to $38.3M in fiscal year 2025.

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Nanobiotix Labege (NNBXF) reported on that line in every period on record.